Experimental myasthenia gravis induced in mice by passive transfer of human myasthenic immunoglobulin. Evidence for an ameliorating effect by alpha-fetoprotein

Ellen Buschman, Nicolai van Oers, Max Katz, Robert A. Murgita

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The induction of experimental autoimmune myasthenia gravis (EAMG) was studied by the passive transfer of γ-globulin from myasthenia gravis (MG) patients to C57BL/6 mice. Muscular weakness and electromyographic decrements (EMG) could be consistently induced in all mice injected with γ-globulin from certain selected MG patients. There was, however, no correlation between the antiacetylcholine receptor antibody titre in the donor γ-globulin and the ability to induce EAMG. The possible beneficial effects of immunoregulatory alphafetoprotein (AFP) treatment were investigated employing the passive EAMG model. Mice were protected against the onset of severe symptoms provided the AFP was administered before and after passive transfer. The exaggerated fatigue characteristics associated with murine EAMG as detected by EMG could be alleviated by AFP treatment. These findings raise the possibility that AFP may be of some therapeutic value in the control of MG.

Original languageEnglish (US)
Pages (from-to)315-330
Number of pages16
JournalJournal of Neuroimmunology
Volume13
Issue number3
DOIs
StatePublished - 1987

Fingerprint

Autoimmune Experimental Myasthenia Gravis
Muscle Weakness
alpha-Fetoproteins
Immunoglobulins
Myasthenia Gravis
Globulins
Inbred C57BL Mouse
Fatigue
Therapeutics
Tissue Donors
Antibodies

Keywords

  • Experimental myasthenia gravis - Myasthenic immunoglobulin
  • human - Alpha-fetoprotein - Mice

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Clinical Neurology
  • Neurology

Cite this

Experimental myasthenia gravis induced in mice by passive transfer of human myasthenic immunoglobulin. Evidence for an ameliorating effect by alpha-fetoprotein. / Buschman, Ellen; van Oers, Nicolai; Katz, Max; Murgita, Robert A.

In: Journal of Neuroimmunology, Vol. 13, No. 3, 1987, p. 315-330.

Research output: Contribution to journalArticle

@article{7eb838ef6d9645e6b07ca941356aea7c,
title = "Experimental myasthenia gravis induced in mice by passive transfer of human myasthenic immunoglobulin. Evidence for an ameliorating effect by alpha-fetoprotein",
abstract = "The induction of experimental autoimmune myasthenia gravis (EAMG) was studied by the passive transfer of γ-globulin from myasthenia gravis (MG) patients to C57BL/6 mice. Muscular weakness and electromyographic decrements (EMG) could be consistently induced in all mice injected with γ-globulin from certain selected MG patients. There was, however, no correlation between the antiacetylcholine receptor antibody titre in the donor γ-globulin and the ability to induce EAMG. The possible beneficial effects of immunoregulatory alphafetoprotein (AFP) treatment were investigated employing the passive EAMG model. Mice were protected against the onset of severe symptoms provided the AFP was administered before and after passive transfer. The exaggerated fatigue characteristics associated with murine EAMG as detected by EMG could be alleviated by AFP treatment. These findings raise the possibility that AFP may be of some therapeutic value in the control of MG.",
keywords = "Experimental myasthenia gravis - Myasthenic immunoglobulin, human - Alpha-fetoprotein - Mice",
author = "Ellen Buschman and {van Oers}, Nicolai and Max Katz and Murgita, {Robert A.}",
year = "1987",
doi = "10.1016/0165-5728(87)90067-1",
language = "English (US)",
volume = "13",
pages = "315--330",
journal = "Journal of Neuroimmunology",
issn = "0165-5728",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Experimental myasthenia gravis induced in mice by passive transfer of human myasthenic immunoglobulin. Evidence for an ameliorating effect by alpha-fetoprotein

AU - Buschman, Ellen

AU - van Oers, Nicolai

AU - Katz, Max

AU - Murgita, Robert A.

PY - 1987

Y1 - 1987

N2 - The induction of experimental autoimmune myasthenia gravis (EAMG) was studied by the passive transfer of γ-globulin from myasthenia gravis (MG) patients to C57BL/6 mice. Muscular weakness and electromyographic decrements (EMG) could be consistently induced in all mice injected with γ-globulin from certain selected MG patients. There was, however, no correlation between the antiacetylcholine receptor antibody titre in the donor γ-globulin and the ability to induce EAMG. The possible beneficial effects of immunoregulatory alphafetoprotein (AFP) treatment were investigated employing the passive EAMG model. Mice were protected against the onset of severe symptoms provided the AFP was administered before and after passive transfer. The exaggerated fatigue characteristics associated with murine EAMG as detected by EMG could be alleviated by AFP treatment. These findings raise the possibility that AFP may be of some therapeutic value in the control of MG.

AB - The induction of experimental autoimmune myasthenia gravis (EAMG) was studied by the passive transfer of γ-globulin from myasthenia gravis (MG) patients to C57BL/6 mice. Muscular weakness and electromyographic decrements (EMG) could be consistently induced in all mice injected with γ-globulin from certain selected MG patients. There was, however, no correlation between the antiacetylcholine receptor antibody titre in the donor γ-globulin and the ability to induce EAMG. The possible beneficial effects of immunoregulatory alphafetoprotein (AFP) treatment were investigated employing the passive EAMG model. Mice were protected against the onset of severe symptoms provided the AFP was administered before and after passive transfer. The exaggerated fatigue characteristics associated with murine EAMG as detected by EMG could be alleviated by AFP treatment. These findings raise the possibility that AFP may be of some therapeutic value in the control of MG.

KW - Experimental myasthenia gravis - Myasthenic immunoglobulin

KW - human - Alpha-fetoprotein - Mice

UR - http://www.scopus.com/inward/record.url?scp=0023104094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023104094&partnerID=8YFLogxK

U2 - 10.1016/0165-5728(87)90067-1

DO - 10.1016/0165-5728(87)90067-1

M3 - Article

C2 - 2432086

AN - SCOPUS:0023104094

VL - 13

SP - 315

EP - 330

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

IS - 3

ER -